Vanderbilt Television News Archive

Search the Archive

Commercial: FDA / Julie / MBC #1196729

NBC Evening News for Thursday, Jul 06, 2017
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

Julie is living with metastatic breast cancer, which is breast cancer that has spread to other parts of her body. She's also taking prescription IBRANCE with an aromatase inhibitors, which is for postmenopausal women with hormone receptor positive, her 2 negative metastatic breast cancer as the first hormonal based therapy. I brands plus letters all was significantly more effective at delaying disease progression versus let resolved. And I brands plus letters all shrunk tumors in over half of th...
Duration:
00:01:17

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.